Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Neutral Rating and 88 Price Target for Nabors Industries

Elaine Mendonca by Elaine Mendonca
February 13, 2024
in Breaking News
0
Digitals market connection
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

As of February 13, 2024, Charles Minervino, an analyst at Susquehanna, has restated his “Neutral” rating on Nabors Industries (NYSE:NBR) and has upheld a price target of $88 for the company. It is worth noting that the average analyst price target for NBR over the past 3 months stands at $137.00. This “Neutral” rating signifies a balanced perspective on the stock’s potential performance, while the maintained price target suggests that the stock is reasonably valued at $88.00. This information can prove to be valuable for individuals who are closely monitoring NBR and contemplating their investment choices.

NBR Stock Price Decline on February 13, 2024: A Closer Look at its Performance and Potential Stability

NBR stock experienced a decline in price momentum on February 13, 2024, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock’s price dropped by 3.97% since the market last closed, closing at $75.78. While the stock remained unchanged in after-hours trading, investors should closely monitor its performance in the coming days to determine if this stability will continue. It is important to consider external factors and conduct thorough research before making any investment decisions regarding NBR stock.

Nabors Industries Ltd. Stock Performance: Total Revenue, Net Income, and EPS Analysis

On February 13, 2024, the stock performance of Nabors Industries Ltd. (NBR) displayed some interesting trends, as indicated by the financial data provided by CNN Money. Let’s delve into the details and analyze the company’s total revenue, net income, and earnings per share (EPS) for the past year and the fourth quarter.

Total Revenue:

Nabors Industries Ltd. reported a total revenue of $3.00 billion for the past year, which is a significant increase of 13.27% compared to the previous year. However, it is worth noting that the total revenue remained flat at $725.80 million since the previous quarter.

Net Income:

The net income of Nabors Industries Ltd. for the past year was -$11.78 million, indicating a loss. However, there has been a significant improvement in net income compared to the previous year, with a growth of 96.73%. In the fourth quarter, the net income increased by 0.0% to -$16.70 million.

Earnings per Share (EPS):

The earnings per share (EPS) is an important metric that reflects a company’s profitability on a per-share basis. For the past year, Nabors Industries Ltd. reported an EPS of -$1.29, indicating a loss per share. However, there has been a significant improvement in EPS, with a growth of 96.83% compared to the previous year. In the fourth quarter, the EPS increased by 70.78% to -$1.83.

Overall, the stock performance of Nabors Industries Ltd. on February 13, 2024, displayed mixed results. While the company experienced a significant increase in total revenue and net income compared to the previous year, the growth remained flat since the previous quarter. The improvement in earnings per share also showcases the company’s efforts towards profitability, although it still reported losses.

Investors and analysts will closely monitor these financial indicators to assess the company’s future prospects. It is important to consider other factors such as market conditions, industry trends, and company strategies to gain a comprehensive understanding of NBR stock performance.

Tags: NBR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Plant based

Marriott International Faces Share Decline Due to Revenue Shortfall and Lower Profit Outlook for 2024

Woman using laptop

Harnessing the Buzz: Transforming Trending Topics into Compelling Press Release Campaigns

Financing and retirement

Navigating the Retirement Redefinition: Unveiling the Next Era of Financial Security

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com